Validation of a LC method for the analysis of zafirlukast in a pharmaceutical formulation

Journal of Pharmaceutical and Biomedical Analysis

Volumn 23, Issue 1, 2000, Pages 169-174

  Ficarra, R ^a   Ficarra, P ^b   Tommasini, S ^b   Melardi, S ^b   Calabro M L ^a   Furlanetto, S ^c   Semreen, M ^b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Experimental design; Intermediate precision; Reversed phase high performance liquid chromatography; Robustness testing; Validation; Zafirlukast

Indexed keywords

ZAFIRLUKAST;

ASSAY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ANALYSIS; DRUG FORMULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; METHODOLOGY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SOLUTION AND SOLUBILITY; STANDARD; TABLET; VALIDATION PROCESS;

ANTI-ASTHMATIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; PHARMACEUTICAL PREPARATIONS; TOSYL COMPOUNDS;

EID: 0034257023     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(00)00266-1     Document Type: Conference Paper

References (13)

1. Adkins J.C., Brogden R.N. Drugs. 55:1998;121-144.
2. Bui K.H., Kennedy C.M., Azumaya C.T., Birmingam B.K. J. Chromatogr. B. 696:1997;131-136.
3. S.B. French, K.H. Bui, ZENECA Pharmaceuticals, unpublished results.
4. W. Nemrod, D. Mathieu, J. Nony, R. Phan-Tan-Luu, LPRAI SARL, Marseilles, F-13331, France.
5. Topic Q2B, Validation of Analytical Methods: Methodology: The Third International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH3, Yokohama, Japan, 29 November-1 December, 1995.
6. Furlanetto S., Pinzauti S., Gratteri P., La Porta E., Calzeroni G. J. Pharm. Biomed. Anal. 15:1997;1585-1594.
7. Altria K.D., Clark B.J., Filbey S.D., Kelly M.A., Rudd D.R. Electrophoresis. 16:1995;2143-2148.
8. Van der Heyden Y., Massart D.L. Hendriks M.M.W.B., de Boer J.H., Smilde A.K. Robustness of Analytical Chemical Methods and Pharmaceutical Technological Products. 1996;33 Elsevier, Amsterdam.
9. Furlanetto S., Tognini C., Carpenedo R., La Porta E., Pinzauti S. J. Pharm. Biomed. Anal. 18:1998;67-73.
10. Furlanetto S., Pinzauti S., La Porta E., Chiarugi A., Mura P., Orlandini S. J. Pharm. Biomed. Anal. 17:1998;1015-1028.
11. Plackett R.L., Burmann J.P. Biometrika. 33:1943;305-325.
12. Lenth R.V. Technometrics. 3:1989;469-473.
13. Lewis G.A., Mathieu D., Phan-Tan-Luu R. Pharmaceutical Experimental Design. 1999;Marcel Dekker, New York.